HTG Molecular Diagnostics Reports Full Year 2018 Results
Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz. , March 07, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission
- Category:
- Press Releases